non-alcoholic fatty liver disease

Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment
Stat
Tue, 09/18/18 - 10:00 am
Viking Therapeutics
NASH
non-alcoholic fatty liver disease
VK2809
clinical trials
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
CP Wire
Fri, 02/23/18 - 07:51 am
BASF
Hepaxa
DIEM Labs
non-alcoholic fatty liver disease
drug launches
Release: BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
Fri, 02/23/18 - 12:28 am
BASF
Hepaxa
drug launches
non-alcoholic fatty liver disease
Fractyl eyes insulin resistance in fatty liver disease
Mass Device
Tue, 11/15/16 - 09:18 am
Fractyl Labs
insulin resistance
non-alcoholic fatty liver disease
Revita
devices
Gilead Fatty Liver Drug Advances to Phase 3
Investopedia
Fri, 10/21/16 - 10:05 am
Gilead Sciences
non-alcoholic fatty liver disease
NASH
selonsertib
Raptor Pharma says may discontinue development of liver drug
Yahoo/Reuters
Mon, 09/14/15 - 08:23 am
Raptor Pharmaceutical
RP103
NASH
non-alcoholic fatty liver disease
Galectin Drug is a Fatty Liver Flop
TheStreet.com
Tue, 07/29/14 - 02:20 pm
Galectin
GR-MD-02
non-alcoholic fatty liver disease
Liver Drug Race: Intercept Pharma Vs. Rivals
Seeking Alpha
Mon, 01/27/14 - 08:21 am
Intercept Pharma
liver disease
OCA
Conatus Pharmaceuticals
Gilead Sciences
Galectin
NASH
non-alcoholic fatty liver disease